|Bid||2.03 x 1000|
|Ask||2.03 x 2200|
|Day's Range||2.01 - 2.06|
|52 Week Range||0.93 - 3.75|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 18 cents. The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
The Medicines Company (MDCO) incurs wider-than-expected loss in the first quarter of 2018. The top line also missed estimates and declined year over year.
Infinity Pharmaceuticals (INFI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Infinity Pharmaceuticals (INFI) sees solid earnings estimate revisions and looks poised to shock the market, and yet seems overlooked by the investors.
The FDA grants a fast track status to Karyopharm's (KPTI) selinexor for treatment of multiple myeloma. Selinexor is also evaluated in several mid- and later-phase studies on multiple cancer indications.
Investors in Infinity Pharmaceuticals (INFI) need to pay close attention to the stock based on moves in the options market lately.
Infinity (INFI) incurs narrower-than-expected Loss in Q4 and expects to report data from the monotherapy expansion and combination dose escalation components of its pipeline candidate IPI-549.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 14 cents. For the year, the company reported that its loss widened to $41.8 million, or 83 cents per share. Revenue ...
Infinity (INFI) announces the achievement of some development milestones for its lead pipeline candidate- IPI-549 and issued financial guidance for 2018.
Categories: Yahoo FinanceIsmailia National Food Industries relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 47. Our analysis is based on comparing Ismailia National Food Industries with the following peers – Ismailia Misr Poultry, Atlas for Land Reclamation & Agricultural Processing, Sharkia National Food and Arab Cotton Ginning Co. ... Read more (Read more...)
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 14 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) shares are soaring Thursday after an upgrade by Wells Fargo. The biopharma company's IPI-549 monotherapy data was selected for a "late-breaker" oral ...
Infinity (INFI) expanded its existing clinical collaboration with Bristol-Myers Squibb for evaluating IPI-549 in combination with Opdivo to include patients with triple negative breast cancer.
Infinity Pharmaceuticals, Inc. (INFI) reported a wider-than-expected loss in second-quarter 2017 due to the termination of an agreement with AbbVie.